SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017007
Filing Date
2017-08-09
Accepted
2017-08-09 16:47:32
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20170630.htm 10-Q 1989460
2 EX-31.1 ptla-ex311_6.htm EX-31.1 9689
3 EX-31.2 ptla-ex312_9.htm EX-31.2 9715
4 EX-32.1 ptla-ex321_8.htm EX-32.1 8765
  Complete submission text file 0001564590-17-017007.txt   6955889

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptla-20170630.xml EX-101.INS 1589965
6 XBRL TAXONOMY EXTENSION SCHEMA ptla-20170630.xsd EX-101.SCH 47859
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20170630_cal.xml EX-101.CAL 39646
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20170630_def.xml EX-101.DEF 181464
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20170630_lab.xml EX-101.LAB 363679
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20170630_pre.xml EX-101.PRE 304793
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 171018566
SIC: 2834 Pharmaceutical Preparations